A5016190625- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- COVID-19 epidemiological studies
- Viral Infections and Vectors
- SARS-CoV-2 detection and testing
- Mosquito-borne diseases and control
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Animal Disease Management and Epidemiology
- Influenza Virus Research Studies
- Vaccine Coverage and Hesitancy
- COVID-19 Pandemic Impacts
- Viral Infections and Outbreaks Research
- COVID-19 and healthcare impacts
University of Trento
2022-2025
Fondazione Bruno Kessler
2022-2025
Kessler Foundation
2022-2023
BackgroundEstimates of the spatiotemporal distribution different mosquito vector species and associated risk transmission arboviruses are key to design adequate policies for preventing local outbreaks reducing number human infections in endemic areas. In this study, we quantified abundance Aedes albopictus aegypti potential three arboviral at an unprecedented resolution areas where no entomological surveillance is available.MethodsWe developed a computational model quantify daily mosquitoes,...
Starting from the final months of 2021, SARS-CoV-2 Omicron variant expanded globally, swiftly replacing Delta, that was dominant at time. Many uncertainties remain about epidemiology Omicron; here, we aim to estimate its generation
Respiratory syncytial virus (RSV) is a leading cause of hospitalisation and mortality in young children globally. The social distancing measures implemented against COVID-19 Lombardy (Italy) disrupted the typically seasonal RSV circulation during 2019-2021 caused substantially more hospitalisations 2021-2022. primary aim this study to quantify immunity gap-defined as increased proportion population naïve infection following relaxation restrictions Lombardy, which has been hypothesised be...
Abstract Background The difficulty in identifying SARS‐CoV‐2 infections has not only been the major obstacle to control COVID‐19 pandemic but also quantify changes proportion of resulting hospitalization, intensive care unit (ICU) admission, or death. Methods We developed a model transmission and vaccination informed by official estimates time‐varying reproduction number estimate that occurred Italy between February 2020 2022. Model outcomes were compared with Italian National surveillance...
Background Respiratory syncytial virus (RSV) is a leading cause of hospitalisation in children worldwide. Recent regulatory approval monoclonal antibody (mAb) nirsevimab for infants and the RSVpreF vaccine pregnant women offers promising approaches to mitigate RSV-associated morbidity. Aim To evaluate potential impacts routine prophylactic campaigns (mAbs targeting or maternal vaccination) introduced 2024/25 season on hospitalisations from RSV lower respiratory tract infections Lombardy,...
Abstract Undernotification of SARS-CoV-2 infections has been a major obstacle to the tracking critical quantities such as infection attack rates and probability severe lethal outcomes. We use model transmission vaccination informed by epidemiological genomic surveillance data estimate number daily occurred in Italy first two years pandemic. that rate ancestral lineages, Alpha, Delta were similar range (10-17%, 95% CI: 7-23%), while Omicron until February 20, 2022, was remarkably higher (51%,...
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Abstract Undernotification of SARS-CoV-2 infections has been a major obstacle to the tracking critical quantities such as infection attack rates and probability severe lethal outcomes. We use model transmission vaccination informed by epidemiological genomic surveillance data estimate number daily occurred in Italy first two years pandemic. that rate ancestral lineages, Alpha, Delta were similar range (10–17%, 95% CI: 7–23%), while Omicron until February 20, 2022, was remarkably higher (51%,...